X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
asc-j9 (17) 17
index medicus (13) 13
curcumin - analogs & derivatives (10) 10
humans (10) 10
male (10) 10
prostate cancer (10) 10
androgens (9) 9
animals (9) 9
oncology (9) 9
androgen receptor (8) 8
cell line, tumor (8) 8
degradation (8) 8
cancer therapies (7) 7
curcumin - pharmacology (7) 7
signal transduction - drug effects (7) 7
castration (6) 6
mice (6) 6
cell movement - drug effects (5) 5
mechanisms (5) 5
metastasis (5) 5
phenylthiohydantoin - analogs & derivatives (5) 5
phenylthiohydantoin - pharmacology (5) 5
prostate (5) 5
androgen antagonists - pharmacology (4) 4
apoptosis (4) 4
cell growth (4) 4
cell proliferation (4) 4
cell proliferation - drug effects (4) 4
curcumin (4) 4
growth (4) 4
immunoglobulins (4) 4
inhibition (4) 4
mice, nude (4) 4
progression (4) 4
proteins (4) 4
therapy (4) 4
antineoplastic agents, hormonal - pharmacology (3) 3
article (3) 3
chemotherapy (3) 3
enzalutamide (3) 3
hematology, oncology and palliative medicine (3) 3
medical research (3) 3
phosphorylation (3) 3
prostate - drug effects (3) 3
prostatic neoplasms - drug therapy (3) 3
prostatic neoplasms - pathology (3) 3
receptors, androgen - metabolism (3) 3
stat3 transcription factor - metabolism (3) 3
time factors (3) 3
xenograft model antitumor assays (3) 3
abiraterone (2) 2
activation (2) 2
androgen (2) 2
androgen deprivation therapy (2) 2
anilides - pharmacology (2) 2
antiandrogen (2) 2
antibiotics (2) 2
antineoplastic agents - pharmacology (2) 2
asc‐j9 (2) 2
biochemistry & molecular biology (2) 2
bladder cancer (2) 2
cancer (2) 2
cell biology (2) 2
cells (2) 2
chemistry (2) 2
chemistry, multidisciplinary (2) 2
chemokine ccl2 - metabolism (2) 2
cisplatin (2) 2
coculture techniques (2) 2
curcumin - pharmacokinetics (2) 2
cytotoxicity (2) 2
degradation enhancer asc-j9 (2) 2
deoxyribonucleic acid--dna (2) 2
docetaxel (2) 2
enhancer of zeste homolog 2 protein - metabolism (2) 2
enzymes (2) 2
expression (2) 2
lipids (2) 2
macrophages (2) 2
macrophages - drug effects (2) 2
micrornas (2) 2
neoplasm invasiveness (2) 2
nitriles - pharmacology (2) 2
original (2) 2
original article (2) 2
pharmacology & pharmacy (2) 2
plga nanoparticles (2) 2
prostate - pathology (2) 2
prostate-cancer (2) 2
prostate-cancer metastasis (2) 2
prostatic neoplasms - metabolism (2) 2
prostatic neoplasms, castration-resistant - drug therapy (2) 2
prostatic neoplasms, castration-resistant - metabolism (2) 2
prostatic neoplasms, castration-resistant - pathology (2) 2
receptors, androgen - drug effects (2) 2
receptors, androgen - genetics (2) 2
resistance (2) 2
side effects (2) 2
stat3 (2) 2
survival (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Molecular Carcinogenesis, ISSN 0899-1987, 12/2016, Volume 55, Issue 12, pp. 2278 - 2290
Journal Article
Cancer Letters, ISSN 0304-3835, 03/2019, Volume 444, pp. 35 - 44
Chemotherapy with docetaxel remains the effective therapy to suppress castration resistant prostate cancer (CRPC) in some patients. However, most chemotherapy... 
ASC-J9 | Prostate cancer | p21 | Docetaxel | Androgen receptor | INDUCED APOPTOSIS | PHOSPHORYLATION | MECHANISMS | CHEMOTHERAPY | THERAPY | ONCOLOGY | PROSTATE-CANCER CELLS | GROWTH | RESISTANCE | PROGRESSION | ASC-J9 (R) | ENZALUTAMIDE
Journal Article
Cancer Letters, ISSN 0304-3835, 03/2018, Volume 417, pp. 182 - 191
ASC-J9® is a recently-developed androgen receptor (AR)-degradation enhancer that effectively suppresses castration resistant prostate cancer (PCa) cell... 
ASC-J9 | Epithelial cells | Stromal cells | Androgen receptor | IC50 | Fibroblasts | Myofibroblasts | Prostate cancer | Prostate therapy | Apoptosis | FDA-approved formula | IC | INHIBITION | ONCOLOGY | ASC-J9 (R)
Journal Article
Journal Article
Journal Article
Journal Article
Cancer Letters, ISSN 0304-3835, 07/2018, Volume 425, pp. 21 - 30
The androgen-deprivation therapy (ADT) to either reduce the androgen biosynthesis (for example, Abiraterone) or to prevent binding of androgen to the androgen... 
ASC-J9 | Sumoylation | Prostate cancer | Invasion | STAT3 | ACTIVATION | STROMAL ANDROGEN RECEPTOR | THERAPY | INHIBITION | GENE | ONCOLOGY | TUMOR-METASTASIS | GROWTH | ABIRATERONE ACETATE | BONE | PROGRESSION
Journal Article
Cancer Letters, ISSN 0304-3835, 2017, Volume 398, pp. 62 - 69
Abstract Despite the success of androgen-deprivation therapy (ADT) with the newly developed anti-androgen enzalutamide (Enz, also known as MDV3100) to suppress... 
Hematology, Oncology and Palliative Medicine | Natural Killer cells | ARv7 | Enzalutamide | METASTASIS | MAST-CELLS | FULL-LENGTH | ASC-J9 | NK CELLS | REPRESSION | ONCOLOGY | IMMUNOTHERAPY | T-CELLS | ABIRATERONE | Chemotaxis, Leukocyte | Alternative Splicing | Coculture Techniques | Humans | Receptors, Androgen - metabolism | Prostatic Neoplasms, Castration-Resistant - immunology | Tumor Microenvironment | Drug Resistance, Neoplasm | Male | MicroRNAs - metabolism | Prostatic Neoplasms, Castration-Resistant - pathology | Receptors, Androgen - drug effects | Time Factors | Killer Cells, Natural - immunology | Lymphocytes, Tumor-Infiltrating - metabolism | Phenylthiohydantoin - pharmacology | Enhancer of Zeste Homolog 2 Protein - metabolism | Antineoplastic Agents, Hormonal - pharmacology | Neoplasm Invasiveness | Down-Regulation | Androgen Antagonists - pharmacology | Prostatic Neoplasms, Castration-Resistant - drug therapy | Prostatic Neoplasms, Castration-Resistant - metabolism | Phenylthiohydantoin - analogs & derivatives | Xenograft Model Antitumor Assays | Cell Movement - drug effects | Phenotype | Animals | Signal Transduction - drug effects | Mice, Nude | Protein Isoforms | Cell Line, Tumor | Cell Proliferation - drug effects | MicroRNAs - genetics | Killer Cells, Natural - metabolism | Lymphocytes, Tumor-Infiltrating - immunology | Medicine, Experimental | Medical research | Killer cells | MicroRNA | Hormones | Prostate cancer
Journal Article
Cancer Letters, ISSN 0304-3835, 2016, Volume 376, Issue 2, pp. 377 - 386
Journal Article
Hypertension, ISSN 0194-911X, 2014, Volume 63, Issue 6, pp. 1345 - 1353
Journal Article